These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38214218)

  • 21. Mechanisms of palmitic acid-conjugated antisense oligonucleotide distribution in mice.
    Chappell AE; Gaus HJ; Berdeja A; Gupta R; Jo M; Prakash TP; Oestergaard M; Swayze EE; Seth PP
    Nucleic Acids Res; 2020 May; 48(8):4382-4395. PubMed ID: 32182359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Properties of nicked and circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligodeoxynucleotides.
    Yamakawa H; Abe T; Saito T; Takai K; Yamamoto N; Takaku H
    Bioorg Med Chem; 1998 Jul; 6(7):1025-32. PubMed ID: 9730239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The endosomal system of primary human vascular endothelial cells and albumin-FcRn trafficking.
    Pannek A; Becker-Gotot J; Dower SK; Verhagen AM; Gleeson PA
    J Cell Sci; 2023 Aug; 136(15):. PubMed ID: 37565427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-selective conjugation of an anticoagulant aptamer to recombinant albumins and maintenance of neonatal Fc receptor binding.
    Schmøkel J; Voldum A; Tsakiridou G; Kuhlmann M; Cameron J; Sørensen ES; Wengel J; Howard KA
    Nanotechnology; 2017 May; 28(20):204004. PubMed ID: 28362634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Labeling of phosphorothioate antisense oligonucleotides with yttrium-90.
    Watanabe N; Sawai H; Endo K; Shinozuka K; Ozaki H; Tanada S; Murata H; Sasaki Y
    Nucl Med Biol; 1999 Feb; 26(2):239-43. PubMed ID: 10100225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted Delivery of Antisense Oligonucleotides Using Neurotensin Peptides.
    Nikan M; Tanowitz M; Dwyer CA; Jackson M; Gaus HJ; Swayze EE; Rigo F; Seth PP; Prakash TP
    J Med Chem; 2020 Aug; 63(15):8471-8484. PubMed ID: 32677436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biophysical properties of tetravalent PEG-conjugated antisense oligonucleotide.
    Rahman Chowdhury T; Taufiq T; Ishida K; Ariful Islam M; Kasahara Y; Osawa T; Obika S
    Bioorg Med Chem; 2023 Jan; 78():117149. PubMed ID: 36587552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient Gene Suppression by DNA/DNA Double-Stranded Oligonucleotide In Vivo.
    Asami Y; Nagata T; Yoshioka K; Kunieda T; Yoshida-Tanaka K; Bennett CF; Seth PP; Yokota T
    Mol Ther; 2021 Feb; 29(2):838-847. PubMed ID: 33290725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Half-life extension of efficiently produced DARPin serum albumin fusions as a function of FcRn affinity and recycling.
    Merten H; Brandl F; Zimmermann M; Schaefer JV; Irpinio L; Sand KMK; Nilsen J; Andersen JT; Zangemeister-Wittke U; Plückthun A
    Eur J Pharm Biopharm; 2021 Oct; 167():104-113. PubMed ID: 34303832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn
    Mester S; Evers M; Meyer S; Nilsen J; Greiff V; Sandlie I; Leusen J; Andersen JT
    MAbs; 2021; 13(1):1893888. PubMed ID: 33691596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nano drug delivery systems for antisense oligonucleotides (ASO) therapeutics.
    Ramasamy T; Ruttala HB; Munusamy S; Chakraborty N; Kim JO
    J Control Release; 2022 Dec; 352():861-878. PubMed ID: 36397636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albumin nanoparticles as carriers for a phosphodiester oligonucleotide.
    Arnedo A; Espuelas S; Irache JM
    Int J Pharm; 2002 Sep; 244(1-2):59-72. PubMed ID: 12204565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folate receptor-targeted lipid-albumin nanoparticles (F-LAN) for therapeutic delivery of an Akt1 antisense oligonucleotide.
    Li H; Liu Y; Chen L; Liu Q; Qi S; Cheng X; Lee YB; Ahn CH; Kim DJ; Lee RJ
    J Drug Target; 2018; 26(5-6):466-473. PubMed ID: 29376449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of Off-Target Effects of Gapmer Antisense Oligonucleotides by Oligonucleotide Extension.
    Yasuhara H; Yoshida T; Sasaki K; Obika S; Inoue T
    Mol Diagn Ther; 2022 Jan; 26(1):117-127. PubMed ID: 34994962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vivo Metabolite Profiles of an
    Li XQ; Elebring M; Dahlén A; Weidolf L
    Drug Metab Dispos; 2023 Oct; 51(10):1350-1361. PubMed ID: 37429729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grafting multi-maleimides on antisense oligonucleotide to enhance its cellular uptake and gene silencing capability.
    Guo Y; Zhang J; Pan G; Choi CHJ; Wang P; Li Y; Zhu X; Zhang C
    Chem Commun (Camb); 2020 Jul; 56(54):7439-7442. PubMed ID: 32494799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of nucleobase chemical modifications that reduce the hepatotoxicity of gapmer antisense oligonucleotides.
    Yoshida T; Morihiro K; Naito Y; Mikami A; Kasahara Y; Inoue T; Obika S
    Nucleic Acids Res; 2022 Jul; 50(13):7224-7234. PubMed ID: 35801870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tracking the down-regulation of folate receptor-α in cancer cells through target specific delivery of quantum dots coupled with antisense oligonucleotide and targeted peptide.
    Zhang MZ; Yu Y; Yu RN; Wan M; Zhang RY; Zhao YD
    Small; 2013 Dec; 9(24):4183-93. PubMed ID: 23828664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of off-target effects of gapmer antisense oligonucleotides using human cells.
    Yoshida T; Naito Y; Yasuhara H; Sasaki K; Kawaji H; Kawai J; Naito M; Okuda H; Obika S; Inoue T
    Genes Cells; 2019 Dec; 24(12):827-835. PubMed ID: 31637814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.